Overview
Severe congenital nemaline myopathy (also known as severe neonatal nemaline myopathy) is the most serious form of nemaline myopathy, a group of inherited neuromuscular disorders characterized by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) in skeletal muscle fibers. This severe form presents at birth or in the neonatal period with profound generalized muscle weakness (hypotonia), minimal or absent spontaneous movements, and severe respiratory insufficiency that typically requires immediate ventilatory support. Affected infants often have significant feeding difficulties requiring tube feeding, and many display a lack of antigravity limb movements. The disease primarily affects the skeletal muscular system, but secondary complications involve the respiratory and gastrointestinal systems. Key clinical features include severe diffuse weakness, absent or markedly reduced deep tendon reflexes, facial weakness, a thin and elongated face, high-arched palate, chest deformities, and joint contractures. Bulbar weakness contributes to swallowing difficulties and aspiration risk. Many affected infants also develop fractures due to osteopenia from immobility. The prognosis is generally poor, with many infants dying within the first year of life due to respiratory failure. Severe congenital nemaline myopathy can be caused by mutations in several genes involved in thin filament structure and function, including ACTA1, NEB, TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, and LMOD3, among others. Diagnosis is confirmed through muscle biopsy showing nemaline rods and genetic testing. There is currently no cure or disease-specific treatment. Management is supportive and includes mechanical ventilation, nutritional support via gastrostomy, physical therapy to manage contractures, and orthopedic interventions as needed. Decisions regarding the extent of life-sustaining interventions are often discussed with families given the severity of the condition.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Severe congenital nemaline myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Severe congenital nemaline myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Severe congenital nemaline myopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Severe congenital nemaline myopathy.
Community
No community posts yet. Be the first to share your experience with Severe congenital nemaline myopathy.
Start the conversation →Latest news about Severe congenital nemaline myopathy
No recent news articles for Severe congenital nemaline myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Severe congenital nemaline myopathy
What is Severe congenital nemaline myopathy?
Severe congenital nemaline myopathy (also known as severe neonatal nemaline myopathy) is the most serious form of nemaline myopathy, a group of inherited neuromuscular disorders characterized by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) in skeletal muscle fibers. This severe form presents at birth or in the neonatal period with profound generalized muscle weakness (hypotonia), minimal or absent spontaneous movements, and severe respiratory insufficiency that typically requires immediate ventilatory support. Affected infants often have significant feeding d
At what age does Severe congenital nemaline myopathy typically begin?
Typical onset of Severe congenital nemaline myopathy is neonatal. Age of onset can vary across affected individuals.